相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Efficacy and safety of COVID-19 vaccines in older people
Roy L. Soiza et al.
AGE AND AGEING (2021)
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
Sabeena Ahmed et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang et al.
LANCET INFECTIOUS DISEASES (2021)
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour et al.
ECLINICALMEDICINE (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Update to the AWED (Applying Wolbachia to Eliminate Dengue) trial study protocol: a cluster randomised controlled trial in Yogyakarta, Indonesia
Katherine L. Anders et al.
TRIALS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action
Emanuele Rizzo
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen
Fatemeh Heidary et al.
JOURNAL OF ANTIBIOTICS (2020)
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed A. C. Siemieniuk et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis
Arunmozhimaran Elavarasi et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
Finny S. Varghese et al.
ANTIVIRAL RESEARCH (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin
M. Y. F. Tay et al.
ANTIVIRAL RESEARCH (2013)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
The pharmacokinetics and interactions of ivermectin in humans - A mini-review
Aranzazu Gonzalez Canga et al.
AAPS JOURNAL (2008)
分享论文
